<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101235741</journal-id>
<journal-id journal-id-type="pubmed-jr-id">32200</journal-id>
<journal-id journal-id-type="nlm-ta">Am J Med Genet A</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Med. Genet. A</journal-id>
<journal-title-group>
<journal-title>American journal of medical genetics. Part A</journal-title>
</journal-title-group>
<issn pub-type="ppub">1552-4825</issn>
<issn pub-type="epub">1552-4833</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29777584</article-id>
<article-id pub-id-type="pmc">6209527</article-id>
<article-id pub-id-type="doi">10.1002/ajmg.a.38708</article-id>
<article-id pub-id-type="manuscript">NIHMS954601</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Neuropsychiatric expression and catatonia in 22q11.2 deletion syndrome: An overview and case series</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Butcher</surname>
<given-names>Nancy J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boot</surname>
<given-names>Erik</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lang</surname>
<given-names>Anthony E.</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A6">6</xref>
<xref ref-type="aff" rid="A7">7</xref>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Andrade</surname>
<given-names>Danielle</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
<xref ref-type="aff" rid="A9">9</xref>
<xref ref-type="aff" rid="A10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vorstman</surname>
<given-names>Jacob</given-names>
</name>
<xref ref-type="aff" rid="A11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McDonald-McGinn</surname>
<given-names>Donna</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A12">12</xref>
<xref ref-type="aff" rid="A13">13</xref>
<xref ref-type="aff" rid="A14">14</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bassett</surname>
<given-names>Anne S.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A15">15</xref>
<xref ref-type="aff" rid="A16">16</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>The 22q and You Center, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA</aff>
<aff id="A2">
<label>2</label>Clinical Genetics Research Program and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada</aff>
<aff id="A3">
<label>3</label>The Dalglish Family 22q Clinic for Adults with 22q11.2 Deletion Syndrome, University Health Network, Toronto, Ontario, Canada</aff>
<aff id="A4">
<label>4</label>De Hartekamp Groep, Centre for People with Intellectual Disability, Haarlem, The Netherlands</aff>
<aff id="A5">
<label>5</label>Institute of Medical Science, University of Toronto, Ontario, Canada</aff>
<aff id="A6">
<label>6</label>Morton and Gloria Shulman Movement Disorders Centre, Toronto Western Hospital and the Edmond J. Safra Program in Parkinson’s Disease Research, University of Toronto, Toronto, Ontario, Canada</aff>
<aff id="A7">
<label>7</label>Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada</aff>
<aff id="A8">
<label>8</label>Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada</aff>
<aff id="A9">
<label>9</label>Division of Neurology, Epilepsy Genetics Program, Toronto Western Hospital, Toronto, Ontario, Canada</aff>
<aff id="A10">
<label>10</label>Krembil Neuroscience Centre, University of Toronto, Toronto, Ontario, Canada</aff>
<aff id="A11">
<label>11</label>Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, the Netherlands</aff>
<aff id="A12">
<label>12</label>Clinical Genetics Centre, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA</aff>
<aff id="A13">
<label>13</label>Department of Pediatrics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA</aff>
<aff id="A14">
<label>14</label>Section of Genetic Counseling, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA</aff>
<aff id="A15">
<label>15</label>Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada</aff>
<aff id="A16">
<label>16</label>Departments of Mental Health and Medicine, Division of Cardiology, and Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada</aff>
<pub-date pub-type="nihms-submitted">
<day>27</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>19</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>10</month>
<year>2019</year>
</pub-date>
<volume>176</volume>
<issue>10</issue>
<fpage>2146</fpage>
<lpage>2159</lpage>
<!--elocation-id from pubmed: 10.1002/ajmg.a.38708-->
<abstract>
<p id="P1">Individuals with 22q11.2 deletion syndrome (22q11.2DS) are at elevated risk of developing treatable psychiatric and neurological disorders, including anxiety disorders, schizophrenia, seizures, and movement disorders, often beginning in adolescence or early to mid adulthood. Here, we provide an overview of neuropsychiatric features associated with 22q11.2DS in adulthood. Results of a new case series of 13 individuals with 22q11.2DS and catatonic features together with 5 previously reported cases support a potential association of this serious psychomotor phenotype with the 22q11.2 deletion. As in the general population, catatonic features in 22q11.2DS occurred in individuals with schizophrenia, other psychotic and non-psychotic psychiatric disorders, and neurological disorders like Parkinson’s disease. We place the results in the context of an updated review of catatonia in genetic conditions. The complex neuropsychiatric expression and risk profile of 22q11.2DS highlights the need to consider co-morbid factors and provide care tailored to the individual patient. The results reinforce the need for periodic monitoring for the emergence of psychiatric and neurological features, including catatonic features. Pending further research, enhanced recognition and informed anticipatory care promise to facilitate the early diagnosis that allows for timely implementation and optimization of effective treatments.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>